Sales & Marketing At BIO 2024, an industry vows to reclaim its narrative At BIO2024 experts agreed that in a period where pharma is deeply unpopular, the industry must be proactive in telling its story.
R&D Headlines and hot topics from ASCO and BIO, with Jonah Comst... This week, pharmaphorum editor-in-chief Jonah Comstock headed to not one, but two back-to-back events in the US.
News Abcuro raises $200m to take muscle disease drug to market Abcuro has raised $200m in financing that should allow it to complete a pivotal trial of ulviprubart for rare disease inclusion body myositis (IBM).
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl